Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment.

Front Oncol · 2023 · PMC10523148 · PMID 37771446

Europe PMC DOI

hedged sentence

0.0740

closest p · 1.5× alpha

0.0740

boldest claim

The sentences

marginal significanceP = 0.074so close (0.05 < p ≤ 0.1)

Of note, ICI combined with assigned treatment was associated with OS with marginal significance (HR, 0.53; 95% CI, 0.27–1.06; P = 0.074).

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.